Brown Advisory Securities, LLC Exelixis, Inc. Transaction History

Brown Advisory Securities, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$16.3 - $21.14 $326,000 - $422,800
-20,000 Closed
0 $0
Q2 2019

Aug 12, 2019
SELL
$18.93 - $24.75 $18,664 - $24,403
-986 Reduced 4.7%
20,000 $427,000
Q1 2019

May 14, 2019
BUY
$19.6 - $24.76 $19,325 - $24,413
986 Added 4.93%
20,986 $500,000
Q2 2017

Aug 14, 2017
BUY
N/A
20,000
20,000 $493,000

Others Institutions Holding EXEL

# of Institutions
503
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Brown Advisory Securities, LLC Portfolio

Follow Brown Advisory Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email